Member access

4-Traders Homepage  >  Shares  >  Euronext Paris  >  Adocia    ADOC   FR0011184241

ADOCIA (ADOC)

457
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Adocia
Provides research and development services to the biotechnology field

Adocia SA is a biotechnology company that specializes in the development of medicines from already approved therapeutic agents.

It is also engaged in the research and development of biotheraphy products used in tissue regeneration and for treating chronic diseases.

Its products include pipeline, PDGF-BB, BioChaperone insulins combo based on Glargine, BioChaperone ultra-fast analog insulin, HinsBet, monoclonal antibodies formulations, and DriveIn-Dox.

The company was founded by Gérard Soula, OLivier Soula, and Rémi Soula on December 16, 2005 and is headquartered in Lyon, France.

Sales per Businesses
20122013Delta
EUR (in Million)%EUR (in Million)%
Regenerating Medicine4.00100%5.59100% +28.51%
Sales per Regions
20122013Delta
EUR (in Million)%EUR (in Million)%
France4.00100%5.59100% +28.51%
Managers
NameAgeSinceTitle
Gérard Soula PhD, MBA672005Chairman, President & Chief Executive Officer
Valérie Danaguezian-2006CFO, Principal Financial & Accounting Officer
Olivier Soula PhD, MBA462005Director, Deputy General Manager, Director-R&D
Olivier Martinez PhD, MBA45-Director
Laurent Arthaud53-Director
Dominique Takizawa592011Independent Director
Jérôme Féraud40-Director
Ekaterina Smirnyagina, PhD492013Independent Director
Rémi Soula, PhD-2005Director-Business Development
José Correia, PhD--Director-Preclinical & Clinical Department
Shareholders
NameShares%
BPIFrance Investissement SAS 1,129,280 16.5%
Gérard Soula PhD, MBA 898,463 13.1%
La Société Hospitalière d'Assurances Mutuelles SA 320,000 4.68%
IDInvest Partners SA 309,320 4.52%
Olivier Soula PhD, MBA 307,490 4.50%
Rémi Soula, PhD 302,490 4.42%
ACG Management SAS 238,192 3.48%
Oreo Finance SAS 191,343 2.80%
Groupe des Assurances du Crédit Mutuel SA 125,944 1.84%
Amundi Private Equity Funds SA 88,878 1.30%
Holdings
NameShares%Valuation
Adocia (ADOC) 40,3260.59%2,401,546 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Bio Therapeutic Drugs
Advertisement
Sector Biotechnology & Medical Research
Growth (Revenue) Profitability
ACTELION LTD
SHANGHAI RAAS BLO..
-
MEDIVATION INC
INTERCEPT PHARMAC..
RECEPTOS INC
JUNO THERAPEUTICS..
-
HUALAN BIOLOGICAL..
BLUEBIRD BIO INC
GENMAB A/S
TONGHUA DONGBAO P..
BEIJING SL PHARMA..
DYAX CORP.
AGIOS PHARMACEUTI..
NEUROCRINE BIOSCI..
AUSPEX PHARMACEUT..
-
CLOVIS ONCOLOGY I..
TESARO INC
CHINA BIOLOGIC PR..
KITE PHARMA INC
PTC THERAPEUTICS,..
Sector Biotechnology & Medical Research
Adocia : Connections
BPIFrance Investissement SAS
Alizé Pharma SAS
ACG Management SAS
Advanced Bioscience Laboratories, Inc.
DIEAU-EDAFIM SA
FAB Pharma SAS
Lyon Pôle Bourse
Institut Mérieux SA
Lyon Place Financière & Tertiaire
Laboratoire Preciliens SAS
Cerenis Therapeutics Holding SA
iSTAR Medical SA
Mérieux NutriSciences Corp.
Capricorn Venture Partners NV
Company contact information
115 avenue Lacassagne
FR-69003 Lyon
France

Phone : +33 (0)4 72 610 610
Fax : +33 (0)4 72 36 39 67
Internet : http://www.adocia.com
Markets and indexes
- PEA / SRD eligible : YES / YES
- Euronext Paris
- Compartiment B
- CAC All Shares / CAC Small, CAC Mid Small, CAC All-Tradable, CAC PME, PEA-PME, EnterNext© PEA-PME 150
Stock Exchange Codes
- ISIN Code :  FR0011184241
- Bloomberg Code :  ADOC:FP
- Reuters Code :  ADOC.PA
- Datastream Code :  
© 2015 People , Fundamentals and Ownership    © 2015 Cofisem   
Dynamic quotes  
ON
| OFF